List
The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.
-
Topic 373: alteRNAting-seq
SBC: ELECTRONIC BIOSCIENCES, INC. Topic: NCIDuring this Phase I SBIR project, Electronic BioSicences (EBS) will develop a direct, long-read, RNA strand sequencing methodology that is capable of sequencing both canonical and specific modified nucleotides with high-accuracy. This will result in the development of technology wherein a single-stranded RNA (ssRNA) molecule is translocated through a nanopore reader using an applied voltage bias a ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 372: Development and Validation of Non- Mouse Reagents to Enable Preclinical Development of Novel Therapeutics
SBC: AVANTGEN INC Topic: NCIThere is an increasing appreciation that dogs with naturally occurring cancers may be a better model system for evaluating cancer therapeutics than the traditional mouse model systems. However, use of dogs for evaluating the emerging class of immunotherapeutics for oncology is limited by the availability of suitable reagents to mentor the response of the canine immune system. The majority of reage ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Topic 372: Development of the Fully Humanized 9-in-9-out Rat Drug Metabolism-CYP450 Model, Using the Active Genetic: Gene Drive Technology
SBC: SYNBAL, INC. Topic: NCIIn this Fast track SBIR grant we aim, by the end of Phase II, to prepare and commercialize a fully humanized rat with Knock-out of many rat drug metabolism related CYP450's (9-in-9-out Rat Drug Metabolism-CYP450 Model) and Knock-in of the human counterpart. IN PHASE I we will develop an Active Genes: Gene Drive (AG:GD) rat - a rat with a properly configured Cas9 to power Active Genetics (AG); AND, ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of an oral drug targeting SUMOylation
SBC: Sumo Biosciences Inc. Topic: 102c Mycand KRas dependent cancerssuch as colorectal cancerrepresent major unmet medical needs that currently lack targeted therapyRecent scientific advances revealed that theseundruggableoncogenes critically depend on post translational modification with the small ubiquitin like modifierSUMOfamily of proteinsand inhibiting SUMOylation inhibits c Myc and KRasFurthermoreSUMOylation inhibition can acti ...
SBIR Phase I 2018 Department of Health and Human Services -
Developing an efficient E-cigarette aerosol generation and exposure system for rodent models with aerosol characteristics equivalent to those inhaled by E-cigarette users
SBC: AUTOMATE SCIENTIFIC, INC. Topic: NIDAAbstract E cigaretteE ciguse has rapidly proliferated worldwideIt is speculated that E cig use may exceed conventional cigarette use withinyearsCigarette smoking is the leading preventable cause of death and disabilityAs E cigs are a relatively new productstudies are needed to determine their long term detrimental effectssome of which may be similar to the long term detrimental effects of nicotine ...
STTR Phase I 2018 Department of Health and Human Services -
Tissue Oxygen Monitoring in Peripheral Vascular Disease
SBC: PROFUSA, INC. Topic: NHLBIDESCRIPTIONprovided by applicantThe goal of this Fast Track SBIR is to demonstrate the functionality of PROFUSAandapos s novel injectable tissue oxygen monitors in patients with peripheral arterial diseasePADand to determine the its ability to detect restenosis in critical limb ischemiaCLIPAD is a manifestation of systemic atherosclerosis that affectsmillion people in the U Swith prevalence increa ...
SBIR Phase II 2018 Department of Health and Human Services -
Scriptmate: A patient-centered mobile system for geriatric prescription medication management
SBC: DIMAGI, INC. Topic: NIAPROJECT SUMMARY Elderly patients are the largest consumers of prescription and non prescription medications and have been reported to account for $million in treatment costs for medication errors likely due to altered pharmacokineticspolypharmacydecline in cognitionand lower health literacyAs a result of this confluence of issues that affect the aging populationmedication management tools designed ...
SBIR Phase I 2018 Department of Health and Human Services -
Smokescreen Translational (TL) Analysis Platform
SBC: BioRealm LLC Topic: 500Project Summary Tobacco attributable disease remains the largest potentially modi able cause of mortalityStrategies to reduce smoking prevalence include developing more effective smoking cessation treatmentsNicotine metabolism and dependence are predictors of smoking behaviorsincluding response to smoking cessation treatmentsThe goal of this Phase II project is to develop prediction models of nico ...
SBIR Phase II 2018 Department of Health and Human Services -
CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care
SBC: C4 Innovations, LLC Topic: 104PROJECT SUMMARY In response to the growing need for training on interventions to address first episode psychosisthe Center for Social InnovationChas partnered with experts in Coordinated Specialty CareCSCto develop and test CSC OnDemandAn Innovative Online Learning Platform for Implementing Coordinated Specialty CareThe product builds on the findings of the Recovery After an Initial Schizophrenia ...
SBIR Phase II 2018 Department of Health and Human Services -
MyoRegulator: A non-invasive neuromodulation device for treatment of spasticity in stroke patients
SBC: PATHMAKER MOBILITY CORP. Topic: 101PROJECT SUMMARYABSTRACT Stroke affects overmillion patients in the U Swith an estimatedadditional cases of stroke occurring each yearOverof stroke survivors have spasticitya disorder of muscle tone that can cause striking impairments in functional movementPharmacologicalsurgical and physical treatments to manage spasticity haveat bestshort term efficacy and are confounded by side effectsIn this NI ...
SBIR Phase I 2018 Department of Health and Human Services